Banque Pictet & Cie Sa Pfizer Inc Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Pfizer Inc stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 13,790 shares of PFE stock, worth $368,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,790

Previous 10,436 32.14%

Holding current value

$368,468

Previous $291,000 37.11%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$27.7 - $31.39 $92,905 - $105,282	3,354 Added 32.14%	13,790 $399,000
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $2,172 - $2,545	86 Added 0.83%	10,436 $291,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $9.63 Million - $12.5 Million	-368,703 Reduced 97.27%	10,350 $297,000
Q3 2023 Nov 27, 2023	SELL	$32.09 - $37.51 $246,290 - $287,889	-7,675 Reduced 1.98%	379,053 $12.6 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $2.63 Million - $3.07 Million	81,956 Added 26.89%	386,728 $12.8 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $2.74 Million - $3.17 Million	75,789 Added 33.1%	304,772 $11.2 Million
Q1 2023 May 01, 2023	SELL	$39.39 - $51.28 $683,377 - $889,656	-17,349 Reduced 7.04%	228,983 $9.34 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $1.59 Million - $2.07 Million	-37,967 Reduced 13.35%	246,332 $0
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $4.67 Million - $5.7 Million	106,763 Added 60.14%	284,299 $12.4 Billion
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $3.51 Million - $4.16 Million	-75,486 Reduced 29.83%	177,536 $9.31 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $639,127 - $791,959	13,970 Added 5.84%	253,022 $13.1 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $141,314 - $209,475	3,420 Added 1.45%	239,052 $14.1 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $1.28 Million - $1.64 Million	32,505 Added 16.0%	235,632 $10.1 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $139,797 - $158,367	-3,893 Reduced 1.88%	203,127 $7.95 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $719,130 - $811,035	-21,473 Reduced 9.4%	207,020 $7.5 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $803,915 - $1.02 Million	-24,019 Reduced 9.51%	228,493 $8.41 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $902,970 - $1.06 Million	-28,440 Reduced 10.12%	252,512 $9.27 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $807,155 - $979,198	26,798 Added 10.54%	280,952 $9.19 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $933,859 - $1.33 Million	-34,549 Reduced 11.97%	254,154 $8.3 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $698,233 - $792,405	-21,210 Reduced 6.84%	288,703 $11.3 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $3.79 Million - $4.91 Million	116,558 Added 60.28%	309,913 $11.1 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $1.41 Million - $1.59 Million	38,213 Added 24.63%	193,355 $8.38 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $258,862 - $284,403	-6,903 Reduced 4.26%	155,142 $6.59 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $698,230 - $796,059	-18,150 Reduced 10.07%	162,045 $7.07 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $861 - $1,045	25 Added 0.01%	180,195 $7.94 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $230,530 - $245,768	6,990 Added 4.04%	180,170 $6.54 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $1.83 Million - $2.12 Million	57,300 Added 49.45%	173,180 $6.15 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $691,043 - $733,220	20,777 Added 21.85%	115,880 $4.2 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $96,100 - $105,865	3,100 Added 3.37%	95,103 $3.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	92,003	92,003 $3.09 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Pfizer Inc Transaction History